{
	"name": "CVE-2017-17678",
	"seq": "2017-17678",
	"type": "CAN",
	"status": "Candidate",
	"phase": {
		"text": "Assigned",
		"date": "20171213"
	},
	"desc": "BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.",
	"refs": [
		{
			"text": "http://bmc.com",
			"source": "MISC",
			"url": "http://bmc.com"
		},
		{
			"text": "http://remedy.com",
			"source": "MISC",
			"url": "http://remedy.com"
		},
		{
			"text": "https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html",
			"source": "MISC",
			"url": "https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html"
		},
		{
			"text": "https://seclists.org/fulldisclosure/2017/Oct/52",
			"source": "MISC",
			"url": "https://seclists.org/fulldisclosure/2017/Oct/52"
		}
	],
	"votes": {}
}
